Skip to main content
Have a personal or library account? Click to login
Efficacy of quercetin derivatives in prevention of ulcerative colitis in rats Cover

Efficacy of quercetin derivatives in prevention of ulcerative colitis in rats

Open Access
|Jul 2013

References

  1. Alarcón de la Lastra C, Martin MJ and Motilva V. (1994). Antiulcer and gastroprotective effects of quercetin: a gross and histologic study.: 56-62.
  2. Amić D, Davidović-Amić D, Beslo D, Rastija V, Lucić B and Trinajstić N. (2007). SAR and QSAR of the antioxidant activity of flavonoids.: 827-845.
  3. Bonacorsi C, Raddi MS, da Fonseca LM, Sannomiya M and Vilegas W. (2012). Effect of Byrsonima crassa and phenolic constituents on Helicobacter pylori- induced neutrophils oxidative burst.133-141.
  4. Boots AW, Haenen GRMM and Bast A. (2008). Health effects of quercetin: From antioxidant to nutraceutical.: 325-337.
  5. Butkovic V, Klasinc L and Bors W. (2004). Kinetic study of flavonoid reactions with stable radicals.: 2816-2820.
  6. Camuesco D, Comalada M, Rodrıguez-Cabezas ME, Nieto A, Lorente MD, Concha A, Zarzuelo A and Galvez J. (2004). The intestinal antiinflammatory effect of quercitrin is associated with an inhibition in iNOS expression.: 908-918.
  7. Guazelli CF, Fattori V, Colombo BB, Georgetti SR, Vicentini FT, Casagrande R, Baracat MM and Verri WA Jr. (2013). Quercetin-loaded microcapsules ameliorate experimental colitis in mice by antiinflammatory and antioxidant mechanisms.(2): 200-208.
  8. Hemnani T and Parihar MS. (1998). Reactive oxygen species and oxidative DNA damage.: 440-452.
  9. Chang KC, Laffin B, Ponder J, Enzsoly A, Nemeth J, Labarbera DV and Petrash JM. (2012). Beta-glucogallin reduces the expression of lipopolysaccharideinduced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues.[Epub ahead of print]
  10. Chuang CC, Martinez K, Xie G, Kennedy A, Bumrungpert A, Overman A, Jia W and McIntosh MK. (2010). Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes.: 1511-1521.
  11. Jacob SW and de la Torre JC. (2009). Pharmacology of dimethyl sulfoxide in cardiac and CNS damage.: 225-35.
  12. Keshavarzian A, Haydek J, Zabihi R, Doria M, D’Astice M and Sorensen JRJ. (1992). Agents capable of eliminating reactive oxygen species: catalase, WR-2721, Cu(II)2(3,5-DIPS)4 decrease experimental colitis.: 1866-1873.
  13. Keshavarzian A, Morgan G, Sedghi S, Gordon JH and Doria M. (1990). Role of reactive oxygen metabolites in experimental colitis.: 786-790.
  14. Kim HP, Mani I and Ziboh VA.(1958). Effects of naturally-occurring flavonoids and bioflavonoids on epidermal cyclooxygenase from guinea pigs.: 17-24.
  15. Lee KM, Hwang MK, Lee DE, Lee KW and Lee HJ (2010). Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells.: 5815-5820.
  16. Loguercio C, D’Argenio G, Delle Cave M, Cosenza V, Della Valle N and Mazzcca Blanco CV. (1996). Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.: 1204-1211.
  17. MacPherson BR and Pfeiffer CJ. (1978). Experimental production of diffuse colitis in rats.: 135-150.
  18. Middleton EJ.(2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.: 673-751.
  19. Morikawa K, Nonaka M, Narahara M, Torii I, Kawaguchi K, Yoshikawa T, Kumazawa Y and Morikawa S. (2003). Inhibitory effect of quercetin on carrageenan- induced inflammation in rats.: 709-721.
  20. Najafzadeh M, Reynolds PD, Baumgartner A and Anderson D. (2009). Flavonoids inhibit the genotoxicity of hydrogen peroxide (H2O2) and of the food mutagen 2-amino-3 methylimadazo[4,5-f]-quinoline (IQ) in lymphocytes from patients with inflammatory bowel disease (IBD).: 405-411.
  21. Noa M, Mas R, Carbaja,D and Valdes S. (2000). Effect of D-002 on acetic acidinduced colitis in rats at single and repeated doses.: 391-395.
  22. Nosal’ova V, Zeman M, Černa S, Navarova J and Zakalova M. (2007). Protective effect of melatonin in acetic acid induced colitis in rats.: 364-370.
  23. Ortega MG, Saragusti AC, Cabrera JL and Chiabrando GA. (2010). Quercetin tetraacetyl derivative inhibits LPS-induced nitric oxide synthase (iNOS) expression in J774A.1 cells.: 105-110.
  24. Rachmilewitz D, Simon PL, Schwartz LW, Griswald DE, Fondacaro JD and Wasserman MA. (1989). Inflammatory mediators of experimental colitis in rats.: 326-327.
  25. Rezaie A, Parker RD and Abdollahi M. (2007). Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?: 2015-2021.
  26. Sanchez de Medina F, Galvez J, Romero JA and Zarzuelo A. (1996). Effect of quercitrin on acute and chronic experimental colitis in the rat.: 771-779.
  27. Sanchez de Medina F, Vera B, Galvez J and Zarzuelo A. (2002). Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat.3097-3108.
  28. Santos NC, Figueira-Coelho J, Martins-Silva J and Saldanha C. (2003). Multidisciplinary utilization of dimethyl sulfoxide: pharmaclogical, cellular and molecular aspects.: 1035-1041.
  29. Veverka M, Gallovič J, Švajdlenka E, Veverkova E, Pronayova N, Milačkova I and Štefek M. (2013). Novel quercetin derivatives: synthesis and screening for anti-oxidant activity and aldose reductase inhibition.: 76-83.
  30. Xiao ZP, Wang XD, Peng ZY, Huang S, Yang P, Li QS, Zhou LH, Hu XJ, Wu LJ, Zhou Y and Zhu HL. (2012). Molecular docking, kinetics study, and structure- activity relationship analysis of quercetin and its analogous as Helicobacter pylori urease inhibitors: 10572-10577.
DOI: https://doi.org/10.2478/intox-2013-0002 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 9 - 12
Published on: Jul 30, 2013
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2013 Ruzena Sotnikova, Viera Nosalova, Jana Navarova, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.